Clinical Trials Browser

Solid Tumor, Adult × osimertinib × 90 days × Clear all

NCT06507306 2026-02-06

A Study to Investigate the Safety and Efficacy of KQB198 as Monotherapy and in Combination in Participants With Advanced Solid Malignancies

Phase 1 Recruiting

Other solid neoplasm

Solid Tumor, Adult